Safety and Pharmacokinetic Study of PF-06651600 in Healthy Volunteers
Completed
Pfizer
Phase 1
This study is a first in human study of PF-06651600. PF-06651600 is being developed for
treatment of inflammatory bowel disease. This study will test single and multiple doses of
PF-06651600. The goal of the study is to assess the safety, tolerability, pharmacokinetics
and pharmacodynamics of PF-06651600 in healthy volunteers.
Bioavailability Study Of PF-06651600 In Healthy Subjects
Completed
Pfizer
Phase 1
PF-06651600 is being developed for treatment of inflammatory bowel disease. This study will
test the bioavailability of a solid dose formulation of PF-06651600 compared to an oral
solution formulation under fasting conditions and the effect of a high fat meal on the
bioavailability of the solid dose formulation of PF-06651600 in healthy subjects. Safety and
tolerability of the tablet and oral solution formulations of PF-06651600 will be assessed
under fasting and fed conditions.
Study To Assess The Efficacy And Safety Of Pf-06651600 In Subjects With Rheumatoid Arthritis With An Inadequate Response To Methotrexate
Completed
Pfizer
Phase 2
This is an 8 week study to assess the efficacy and safety profile of PF-06651600 in
seropositive subjects with rheumatoid arthritis with an inadequate response to methotrexate
(up to approximately 50% of subjects may also have had an inadequate response to 1 anti-TNF
biologic).
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
